Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
SourceJournal of Geriatric Oncology, 11, 3, (2020), pp. 463-469
Article / Letter to editor
Display more detailsDisplay less details
Journal of Geriatric Oncology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.